Enhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Wibrand, Karin ^a   Berge, Kjetil ^b   Messaoudi, Michaël ^c   Duffaud, Anaïs ^c   Panja, Debabrata ^a   Bramham, Clive R ^a   Burri, Lena ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b former employee of Aker BioMarine Antarctic AS   (Norway)

^c ETAP Applied Ethology   (France)

Author keywords

BDNF; Cognition; Depression; Fatty acids; Imipramine; Krill oil; Omega 3; Phospholipids

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FISH OIL; IMIPRAMINE; KRILL OIL; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; AVERSIVE LIGHT STIMULUS AVOIDANCE TEST; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; IMMOBILIZATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PSYCHOLOGIC TEST; RAT; SUPPLEMENTATION; UNAVOIDABLE AVERSIVE LIGHT STIMULUS TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; CYTOSKELETAL PROTEINS; DEPRESSION; DIETARY FATS, UNSATURATED; EUPHAUSIACEA; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IMIPRAMINE; MALE; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NOOTROPIC AGENTS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SWIMMING;

EUPHAUSIACEA; RATTUS;

EID: 84872825432     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-6     Document Type: Article

References (68)

1. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N, Adv Food Nutr Res 2012 65 211 222 22361189
2. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Br J Nutr 2012 107 Suppl 2 201 S213 22591894
3. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Miles EA, Calder PC, Br J Nutr 2012 107 Suppl 2 171 S184 22591891
4. Marine n-3 fatty acids for cardiovascular risk reduction and disease control in rheumatoid arthritis: "kill two birds with one stone"? Rontoyanni VG, Sfikakis PP, Kitas GD, Protogerou AD, Curr Pharm Des 2012 18 1531 1542 22364137
5. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. O'Brien JS, Sampson EL, J Lipid Res 1965 6 545 551 5865383
6. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Gamoh S, Hashimoto M, Hossain S, Masumura S, Clin Exp Pharmacol Physiol 2001 28 266 270 10.1046/j.1440-1681.2001.03437.x 11251638
7. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Gamoh S, Hashimoto M, Sugioka K, Shahdat Hossain M, Hata N, Misawa Y, Masumura S, Neuroscience 1999 93 237 241 10.1016/S0306-4522(99)00107-4 10430487
8. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L, Eur J Clin Invest 2005 35 691 699 10.1111/j.1365-2362.2005.01570.x 16269019
9. On the role of the hippocampus in learning and memory in the rat. Jarrard LE, Behav Neural Biol 1993 60 9 26 10.1016/0163-1047(93)90664-4 8216164
10. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ, Arch Gen Psychiatry 2005 62 397 408 10.1001/archpsyc.62.4.397 15809407
11. Hippocampal volume and depression: a meta-analysis of MRI studies. Videbech P, Ravnkilde B, Am J Psychiatry 2004 161 1957 1966 10.1176/appi.ajp. 161.11.1957 15514393
12. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Lin PY, Huang SY, Su KP, Biol Psychiatry 2010 68 140 147 10.1016/j.biopsych.2010.03.018 20452573
13. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH, Am J Psychiatry 2006 163 1098 1100 10.1176/appi.ajp.163.6.1098 16741212
14. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Carlezon WA Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF, Biol Psychiatry 2005 57 343 350 10.1016/j.biopsych.2004.11.038 15705349
15. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI, J Lipid Res 2006 47 172 180 16210728
16. Omega-3 fatty acids on the forced-swimming test. Huang SY, Yang HT, Chiu CC, Pariante CM, Su KP, J Psychiatr Res 2008 42 58 63 10.1016/j.jpsychires.2006. 09.004 17070845
17. N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. Park Y, Moon HJ, Kim SH, J Nutr Biochem 2012 23 924 928 10.1016/j.jnutbio.2011.04.018 21852084
18. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R, Psychoneuroendocrinology 2009 34 199 211 10.1016/j.psyneuen.2008.08.025 18848400
19. Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Alme MN, Wibrand K, Dagestad G, Bramham CR, Neural Plast 2007 2007 26496 18301726
20. Neuronal plasticity: a link between stress and mood disorders. Calabrese F, Molteni R, Racagni G, Riva MA, Psychoneuroendocrinology 2009 34 Suppl 1 208 216 19541429
21. A neurotrophic model for stress-related mood disorders. Duman RS, Monteggia LM, Biol Psychiatry 2006 59 1116 1127 10.1016/j.biopsych.2006.02.013 16631126
22. Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Fumagalli F, Caffino L, Racagni G, Riva MA, Eur Neuropsychopharmacol 2009 19 402 408 10.1016/j.euroneuro.2009.01.003 19223270
23. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Kuipers SD, Bramham CR, Curr Opin Drug Discov Devel 2006 9 580 586 17002218
24. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ, Biol Psychiatry 2007 61 187 197 10.1016/j.biopsych.2006.03.021 16697351
25. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Mannisto PT, Castren E, Neuropsychopharmacology 2007 32 2152 2162 10.1038/sj.npp.1301345 17314919
26. Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba. Winther B, Hoem N, Berge K, Reubsaet L, Lipids 2011 46 25 36 10.1007/s11745-010-3472-6 20848234
27. Krill for human consumption: nutritional value and potential health benefits. Tou JC, Jaczynski J, Chen YC, Nutr Rev 2007 65 63 77 17345959
28. The antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciens. Nishioka Y, Oyagi A, Tsuruma K, Shimazawa M, Ishibashi T, Hara H, Biofactors 2011 37 25 30 10.1002/biof.130 21328624
29. Impact of astaxanthin-enriched algal powder of Haematococcus pluvialis on memory improvement in BALB/c mice. Zhang X, Pan L, Wei X, Gao H, Liu J, Environ Geochem Health 2007 29 483 489 10.1007/s10653-007-9117-x 17721823
30. Krill-derived phospholipids rich in n-3 fatty acid improve spatial memory in adult rats. Gamoh S, J Agric Sci 2011 3 3 12
31. Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats. Bisson JF, Nejdi A, Rozan P, Hidalgo S, Lalonde R, Messaoudi M, Br J Nutr 2008 100 94 101 18179729
32. Impact of sugar replacers on cognitive performance and function in rats. Rozan P, Deremaux L, Wils D, Nejdi A, Messaoudi M, Saniez MH, Br J Nutr 2008 100 1004 1010 10.1017/S0007114508971294 18377689
33. Effects of alnespirone (S 20499) in the depression model (Unavoidable aversive light stimulus test) in rats. Messaoudi M, Tricoire A, Jung PH, Desor D, Mocaer E, Lesourd M, Eur Neuropsychopharmacol 1996 6 52
34. Chronic imipramine effects on exploratory behavior in rats. Hughes RN, Pither JM, Pharmacol Biochem Behav 1987 27 359 362 10.1016/0091-3057(87)90581-8 3628450
35. Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats. Messaoudi M, Bisson JF, Nejdi A, Rozan P, Javelot H, Nutr Neurosci 2008 11 269 276 10.1179/147683008X344165 19000380
36. Preliminary Clinical Evaluation of Toxicity and Efficacy of A New Astaxanthin-rich Haematococcus pluvialis Extract. Satoh A, Tsuji S, Okada Y, Murakami N, Urami M, Nakagawa K, Ishikura M, Katagiri M, Koga Y, Shirasawa T, J Clin Biochem Nutr 2009 44 280 284 10.3164/jcbn.08-238 19430618
37. Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression. Shaldubina A, Nemets B, Bersudsky Y, Acta Neuropsychiatrica 2002 14 203 206 10.1034/j.1601-5215.2002.140501.x
38. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Bisogno T, Collu M, Batetta B, et al. Int Dairy J 2010 20 231 235 10.1016/j.idairyj.2009.11.015
39. Review. Marine omega-3 phospholipids: metabolism and biological activities. Burri L, Hoem N, Banni S, Berge K, Int J Mol Sci 2012 13 15401 15419 10.3390/ijms131115401 23203133
40. Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Grimstad T, Bjorndal B, Cacabelos D, Aasprong OG, Janssen EA, Omdal R, Svardal A, Hausken T, Bohov P, Portero-Otin M, et al. Scand J Gastroenterol 2012 47 49 58 22126533
41. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, et al. J Clin Endocrinol Metab 2005 90 2522 2530 10.1210/jc.2004-1667 15705924
42. The immunoregulatory effects of antidepressants. Maes M, Hum Psychopharmacol 2001 16 95 103 10.1002/hup.191 12404604
43. Paroxetine for the prevention of depression induced by high-dose interferon alfa. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH, N Engl J Med 2001 344 961 966 10.1056/NEJM200103293441303 11274622
44. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH, Biol Psychiatry 2003 54 906 914 10.1016/S0006-3223(03)00173-2 14573318
45. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, et al. Mol Psychiatry 2002 7 942 947 10.1038/sj.mp.4001119 12399946
46. C-reactive protein: risk factor, biomarker and/or therapeutic target? Genest J, Can J Cardiol 2010 26 Suppl A 41A 44A 20386760
47. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F, Lancet Neurol 2005 4 371 380 10.1016/S1474-4422(05)70099-5 15907742
48. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. Deutsch L, J Am Coll Nutr 2007 26 39 48 17353582
49. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Park JS, Chyun JH, Kim YK, Line LL, Chew BP, Nutr Metab (Lond) 2010 7 18 10.1186/1743-7075-7-18
50. Role of neurotrophic factors in depression. Castren E, Voikar V, Rantamaki T, Curr Opin Pharmacol 2007 7 18 21 10.1016/j.coph.2006.08.009 17049922
51. The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Vines A, Delattre AM, Lima MM, Rodrigues LS, Suchecki D, Machado RB, Tufik S, Pereira SI, Zanata SM, Ferraz AC, Neuropharmacology 2012 62 184 191 10.1016/j.neuropharm.2011.06.017 21740919
52. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. Wu A, Ying Z, Gomez-Pinilla F, J Neurotrauma 2011 28 2113 2122 10.1089/neu.2011.1872 21851229
53. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC, Durand G, J Lipid Res 1997 38 680 689 9144083
54. Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Ikemoto A, Nitta A, Furukawa S, Ohishi M, Nakamura A, Fujii Y, Okuyama H, Neurosci Lett 2000 285 99 102 10.1016/S0304-3940(00)01035-1 10793236
55. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Rao JS, Ertley RN, Lee HJ, DeMar JC Jr, Arnold JT, Rapoport SI, Bazinet RP, Mol Psychiatry 2007 12 36 46 10.1038/sj.mp.4001888 16983391
56. Identification of genes co-upregulated with Arc during BDNF-induced long-term potentiation in adult rat dentate gyrus in vivo. Wibrand K, Messaoudi E, Havik B, Steenslid V, Lovlie R, Steen VM, Bramham CR, Eur J Neurosci 2006 23 1501 1511 10.1111/j.1460-9568.2006.04687.x 16553613
57. The Arc of synaptic memory. Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, Panja D, Schubert M, Soule J, Tiron A, Wibrand K, Exp Brain Res 2010 200 125 140 10.1007/s00221-009-1959-2 19690847
58. New views of Arc, a master regulator of synaptic plasticity. Shepherd JD, Bear MF, Nat Neurosci 2011 14 279 284 10.1038/nn.2708 21278731
59. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. Gil-Bea FJ, Solas M, Mateos L, Winblad B, Ramirez MJ, Cedazo-Minguez A, Hippocampus 2011 21 999 1009 20865740
60. Balancing Arc synthesis, mRNA decay, and proteasomal degradation: maximal protein expression triggered by rapid eye movement sleep-like bursts of muscarinic cholinergic receptor stimulation. Soule J, Alme M, Myrum C, Schubert M, Kanhema T, Bramham CR, J Biol Chem 2012 287 22354 22366 10.1074/jbc.M112. 376491 22584581
61. Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC). Teber I, Kohling R, Speckmann EJ, Barnekow A, Kremerskothen J, Brain Res Mol Brain Res 2004 121 131 136 10.1016/j.molbrainres.2003.11.017 14969744
62. Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Blusztajn JK, Liscovitch M, Richardson UI, Proc Natl Acad Sci USA 1987 84 5474 5477 10.1073/pnas.84.15.5474 3474663
63. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, et al. Pharmacol Biochem Behav 1997 58 1123 1129 10.1016/S0091-3057(97)00300-6 9408223
64. The effects of Garum Armoricum on elevated-plus maze and conditioned light extinction tests in rats. Messaoudi M, Lalonde R, Nejdi A, Bisson JF, Rozan P, Javelot H, Schroeder H, Curr Topics Nutraceutical Res 2008 6 41 46
65. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Porsolt RD, Anton G, Blavet N, Jalfre M, Eur J Pharmacol 1978 47 379 391 10.1016/0014-2999(78)90118-8 204499
66. Depression: a new animal model sensitive to antidepressant treatments. Porsolt RD, Le Pichon M, Jalfre M, Nature 1977 266 730 732 10.1038/266730a0 559941
67. Antidepressant effects of apocynum venetum leaves in a forced swimming test. Butterweck V, Nishibe S, Sasaki T, Uchida M, Biol Pharm Bull 2001 24 848 851 10.1248/bpb.24.848 11456130
68. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Andersen CL, Jensen JL, Orntoft TF, Cancer Res 2004 64 5245 5250 10.1158/0008-5472.CAN-04- 0496 15289330